Abstract
Piericidin is a potent inhibitor of the mitochondrial and bacterial type I NADH-ubiquinone oxidoreductases (Complex I) and is considered to bind at or close to the ubiquinone binding site(s) of the enzyme. Piericidin-resistant mutants of the bacterium Rhodobacter capsulatus have been isolated and the present work demonstrates that a single missense mutation at the level of the gene encoding the peripheral 49-kDa/NUOD subunit of Complex I is definitely associated with this resistance. Based on this original observation, we propose a model locating the binding site for piericidin (and quinone) at the interface between the hydrophilic and hydrophobic domains of Complex I.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Anti-Bacterial Agents / metabolism
-
Anti-Bacterial Agents / pharmacology*
-
Binding Sites
-
Drug Resistance, Microbial
-
Enzyme Inhibitors / metabolism
-
Enzyme Inhibitors / pharmacology
-
Molecular Sequence Data
-
Mutation
-
NAD(P)H Dehydrogenase (Quinone) / antagonists & inhibitors*
-
NAD(P)H Dehydrogenase (Quinone) / genetics
-
NAD(P)H Dehydrogenase (Quinone) / metabolism
-
Pyridines / metabolism
-
Pyridines / pharmacology
-
Quinones / chemistry
-
Rhodobacter capsulatus / drug effects*
-
Rhodobacter capsulatus / enzymology
-
Rhodobacter capsulatus / genetics
-
Rotenone / metabolism
-
Rotenone / pharmacology*
Substances
-
Anti-Bacterial Agents
-
Enzyme Inhibitors
-
Pyridines
-
Quinones
-
Rotenone
-
piericidin A
-
NAD(P)H Dehydrogenase (Quinone)